Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

In the past two years we have observed 4 patients with manifestations of deranged function of the central nervous system in whom hyponatremia appeared to be related to an abnormal secretion of ...

Nephrodite, Inc., a medical device company developing an implantable, continuous renal replacement system, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...